1. Home
  2. INLX vs EPIX Comparison

INLX vs EPIX Comparison

Compare INLX & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INLX
  • EPIX
  • Stock Information
  • Founded
  • INLX 1996
  • EPIX 2009
  • Country
  • INLX United States
  • EPIX Canada
  • Employees
  • INLX N/A
  • EPIX N/A
  • Industry
  • INLX EDP Services
  • EPIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • INLX Technology
  • EPIX Health Care
  • Exchange
  • INLX Nasdaq
  • EPIX Nasdaq
  • Market Cap
  • INLX 60.5M
  • EPIX 65.3M
  • IPO Year
  • INLX N/A
  • EPIX N/A
  • Fundamental
  • Price
  • INLX $14.47
  • EPIX $1.71
  • Analyst Decision
  • INLX
  • EPIX Hold
  • Analyst Count
  • INLX 0
  • EPIX 3
  • Target Price
  • INLX N/A
  • EPIX $2.00
  • AVG Volume (30 Days)
  • INLX 3.5K
  • EPIX 276.9K
  • Earning Date
  • INLX 05-16-2025
  • EPIX 05-08-2025
  • Dividend Yield
  • INLX N/A
  • EPIX N/A
  • EPS Growth
  • INLX N/A
  • EPIX N/A
  • EPS
  • INLX N/A
  • EPIX N/A
  • Revenue
  • INLX $18,018,373.00
  • EPIX N/A
  • Revenue This Year
  • INLX $7.58
  • EPIX N/A
  • Revenue Next Year
  • INLX N/A
  • EPIX N/A
  • P/E Ratio
  • INLX N/A
  • EPIX N/A
  • Revenue Growth
  • INLX 6.70
  • EPIX N/A
  • 52 Week Low
  • INLX $5.85
  • EPIX $1.40
  • 52 Week High
  • INLX $16.50
  • EPIX $7.88
  • Technical
  • Relative Strength Index (RSI)
  • INLX 55.56
  • EPIX 51.16
  • Support Level
  • INLX $12.00
  • EPIX $1.74
  • Resistance Level
  • INLX $14.99
  • EPIX $1.85
  • Average True Range (ATR)
  • INLX 0.67
  • EPIX 0.08
  • MACD
  • INLX -0.09
  • EPIX -0.01
  • Stochastic Oscillator
  • INLX 66.40
  • EPIX 13.33

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

About EPIX ESSA Pharma Inc.

ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.

Share on Social Networks: